lamdis

How to appeal a Cosentyx denial

Reviewed · 16 sources

The short answer

Cosentyx denials usually come down to prior authorization. Plans want the diagnosis documented, a specialist prescriber, and for some conditions, an older treatment tried first. Ask for the plan's written criteria, then have your doctor answer each point with dated records. If Cosentyx is not on your plan's drug list, ask for a formulary exception.

The appeal at a glance
  1. StartThe denial letterFind what was denied, the reason, and the deadline to appeal.
  2. Step 1Appeal to your planMost plans give you 60 to 180 days to ask. The plan reviews its own decision.
  3. Step 2Go outside the planIf it says no again, someone outside the plan can decide: an independent reviewer, a hearing, or a federal office.

Can’t wait? If waiting could seriously harm your health, ask for a fast appeal. Most plans must decide within 72 hours.

What Cosentyx is approved for

Cosentyx (secukinumab) blocks interleukin-17A. As of November 2026 its FDA label lists six uses: plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, enthesitis-related arthritis in children, and moderate to severe hidradenitis suppurativa. Age limits differ by use.

Why plans deny Cosentyx

Prior authorization. One insurer's national policy recommends prior authorization for Cosentyx injections and requires a specialist for the first approval.

No trial of an older drug. For psoriasis, the policy asks that the patient tried at least one traditional systemic agent for psoriasis for 3 months, such as methotrexate, unless they could not tolerate it or already tried a biologic. For hidradenitis suppurativa, it asks that the patient tried at least one other therapy, such as antibiotics or steroid injections.

Plan preference. In that insurer's national formulary program, Cosentyx is a Step 1 preferred product for several conditions, but other plans may prefer a different drug and require it first.

The renewal lacked proof. Renewals ask for a beneficial response by an objective measure and improvement in symptoms.

Reading the denial

Job-based plans must name the specific plan provision behind a denial, and you can ask for a free copy of the criteria. "Criteria not met" means the plan wanted more medical proof; see prior authorization denials. "Step therapy" or "try a preferred product first" means the plan wants another drug tried; see step therapy denials. "Non-formulary" means Cosentyx is not on the drug list, which calls for a formulary exception. Check your plan's drug list to see what it prefers.

What your doctor's letter should document

Ask for a letter of medical necessity that answers each criterion, in order, with dated records:

  • The diagnosis and its diagnosis code, with severity measures such as body surface area or a hidradenitis severity score.
  • Every prior treatment: drug, dose, dates and result.
  • Any reason an older drug is unsafe for you.
  • The specialist's role.
  • For renewals, measurements from before Cosentyx and now.

Ask the plan for the written criteria it used. Job-based plans must name the specific plan provision behind a denial and give you a free copy of any criteria they relied on. File the internal appeal within 180 days of the denial.

If Cosentyx is not on the drug list, ask for a formulary exception instead of, or alongside, the appeal. Your doctor generally confirms that covered drugs have not worked, will not work as well, or are likely to cause harm. Individual and small-group plans must decide a standard request within 72 hours and an expedited one within 24 hours, and a denial can go to an independent reviewer. See formulary exception letters.

If the plan upholds a denial that turned on medical judgment, you can ask for external review within 4 months of the final decision. Your insurer has to accept the reviewer’s decision.

Medicare, Medicaid and manufacturer help

With a Medicare drug plan, ask for a coverage determination or exception. Your prescriber must provide a statement explaining the medical reason. The plan must decide within 72 hours, or 24 hours if expedited, and Part D exceptions can also cover step therapy and dose limits. You have 65 days to appeal a denial. See Part D appeals.

When a clinic gives the drug, Medicare may pay under Part B instead. Medicare.gov says Part B usually covers drugs you wouldn’t typically give to yourself, like those given in a doctor's office, and most injectable and infused drugs when a licensed provider gives them. Ask the clinic which part of Medicare it is billing, because the appeal path differs. See Original Medicare appeals.

State Medicaid programs may require prior authorization for any covered drug. See Medicaid appeals.

Novartis says that, if eligible, Co-Pay Plus may help pay for Cosentyx, including refills.

Questions people ask

What do I need to try before Cosentyx?

It depends on the condition and plan. One policy asks for a traditional systemic drug for psoriasis and one other therapy for hidradenitis suppurativa. Ask for your plan's written criteria.

Why was my Cosentyx renewal denied?

Renewals usually need proof the drug is working, such as a better skin, joint or lesion measure than before you started, plus fewer symptoms. Ask your doctor to send measurements from before Cosentyx and now. You can ask for a free copy of the renewal criteria.

Insurance stopped covering Cosentyx after I'd been on it. What can I do?

First find out why: a lapsed prior authorization, a renewal that asked for proof the drug is working, or a drug-list change. Ask your doctor to resubmit with current records. In individual and small-group plans, being in the middle of a course of treatment on a non-formulary drug qualifies for a 24-hour expedited exception. Medicare drug plans must offer a temporary supply in the first 90 days under a new plan, and that process also covers current enrollees affected by formulary changes.

What if my Cosentyx appeal is denied?

If the denial turned on medical judgment, you can ask for external review by an independent reviewer within 4 months of the plan's final decision. A denied formulary exception in an individual or small-group plan can also go to independent review. With Medicare Part D, if the plan upholds its denial you have 60 days to ask a Part D Independent Review Entity to reconsider; see Part D appeals.

Sources

  1. National Library of Medicine (DailyMed): COSENTYX (secukinumab) prescribing information (DailyMed)COSENTYX is a human interleukin-17A antagonist indicated for the treatment of
  2. Cigna Healthcare: Inflammatory Conditions – Cosentyx Subcutaneous Prior Authorization Policy (Cigna National Formulary, review date 10/29/2025, revised 2026)Prior Authorization is recommended for prescription benefit coverage of Cosentyx
  3. Cigna Healthcare: Inflammatory Conditions Preferred Specialty Management Policy for National Preferred and Basic Formularies (Cigna, review date 07/29/2026)this program requires trial(s) of the Preferred Product(s) according to the table below when clinically appropriate, prior to the approval of the Non-Preferred Products
  4. eCFR (Office of the Federal Register): 29 CFR 2560.503-1 -- Claims procedureReference to the specific plan provisions on which the determination is based
  5. HealthCare.gov: Getting prescription medicationsVisit your insurer’s website to review a list of prescriptions your plan covers
  6. HealthCare.gov: Internal appealsYou must file your internal appeal within 180 days (6 months) of receiving notice that your claim was denied.
  7. eCFR (Office of the Federal Register): 45 CFR 156.122 -- Prescription drug benefitsA health plan must make its determination on a standard exception and notify the enrollee or the enrollee's designee and the prescribing physician (or other prescriber, as appropriate) of its coverage determination no later than 72 hours following receipt of the request.
  8. HealthCare.gov: External ReviewYou must file a written request for an external review within 4 months after the date you receive a notice or final determination from your insurer that your claim has been denied.
  9. Medicare.gov: Appeals in a Medicare drug planIf you're asking for an exception, your prescriber must provide a statement explaining the medical reason why the exception should be approved.
  10. eCFR (Office of the Federal Register): 42 CFR 423.568 -- Standard timeframe and notice requirements for coverage determinationsbut no later than 72 hours after receipt of the physician's or other prescriber's supporting statement
  11. eCFR (Office of the Federal Register): 42 CFR 423.572 -- Timeframes and notice requirements for expedited coverage determinationsbut no later than 24 hours after receipt of the physician's or other prescriber's supporting statement
  12. eCFR (Office of the Federal Register): 42 CFR 423.578 -- Exceptions processAn exception to a plan's coverage policy that causes a Part D prescription drug not to be covered because of cost utilization tools, such as a requirement for step therapy, dosage limitations, or therapeutic substitution.
  13. Legal Information Institute, Cornell Law School: 42 U.S. Code § 1396r-8 - Payment for covered outpatient drugsA State may subject to prior authorization any covered outpatient drug
  14. Medicare.gov: Prescription drugs (outpatient)Usually, Part B covers drugs you wouldn't typically give to yourself, like those you get at a doctor's office or in a hospital outpatient setting.
  15. Novartis: COSENTYX Connect personal support programIf eligible, Co-Pay Plus may help you pay for your COSENTYX, including refills.
  16. eCFR (Office of the Federal Register): 42 CFR 423.120 -- Access to covered Part D drugsEnsure access to a temporary supply of drugs within the first 90 days of coverage under a new plan.

This page is general information about appeal rules in the United States. It is not legal or medical advice. Rules can change, and your plan’s documents and your denial letter control the dates that apply to you.